IDWeek 2025 heads to Atlanta October 19–22 with cutting-edge sessions on AMR, AI, vaccines, HIV, pediatrics, and global health challenges. The infectious diseases community will gather in Atlanta from ...
A pair of roflumilast clinical trial investigators react to the FDA approval of the 0.05% formulation to treat atopic dermatitis in children aged 2 to 5 years. A newly approved nonsteroidal topical ...
As team sports ramp up this fall, pediatricians can expect the return of a familiar question from parents: “What should my child eat before the big game?” Sports nutrition is not just a modified ...
New CDC data show fewer kindergartners are fully vaccinated as exemption rates increased during the 2024-2025 school year. Vaccination coverage among kindergartners in the United States declined ...
A new polygenic risk score enhances obesity risk prediction from childhood to adulthood, offering new insights for early intervention and prevention strategies. An international team of researchers ...
Parents and pediatricians navigate the complexities of neurodiversity, emphasizing the need for open communication and better resources for child development. For many parents, the idea of ...
Pelthos Therapeutics has launched berdazimer (Zelsuvmi) topical gel, 10.3%, for the treatment of molluscum contagiosum in adults and pediatric patients aged 1 year and older, according to a company ...
Specifically, the ACIP voted 5-2 to recommend clesrovimab (Enflonsia; Merck), which was approved by the FDA on June 9, 2025, for infants aged 8 months and younger who are not protected by a maternal ...
Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks. The FDA will not meet a prescription drug user fee act (PDUFA) ...
The AI-enabled, wearable device is the first FDA-approved, drug-free solution for nasal congestion and allergies in children ages 12 and up. The FDA has approved an expanded pediatric indication for ...
RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule. "I couldn't be more ...
The approved indication now includes children down to 6 weeks of age to protect against invasive meningococcal disease via serogroups A, C, W, and Y. On May 23, 2025, the FDA approved an expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback